10 results match your criteria: "Institute of Hematology Hospital of Blood Disease[Affiliation]"

Dendritic cells (DCs) play a central role in autoimmunity, immune homeostasis, and presentation of tumor antigens to T cells in order to prime antitumor responses. The number of tumor-infiltrating DCs is associated with survival and prognosis in cancer. Twist1 is a well-known regulator of tumor initiation and promotion, but whether and how DC-derived Twist1 regulates antitumor responses remains poorly understood.

View Article and Find Full Text PDF

Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and .

Cancer Cell Int

February 2019

1Department of Obstetrics and Gynecology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, No. 150 Ximen Street, Linhai, 317000 Zhejiang China.

Background: The study purpose was to make investigation into the influence of XIST on cervical cancer progression and what's more its potential mechanism.

Methods: The cervical cancer data sets (lncRNA, miRNA, and mRNA) obtained from TCGA were analyzed with the "mixOmics" R package. Then, the expression of XIST, miR-140-5p, and were detected using qRT-PCR and western blot in both tissues and cervical cancer cell lines (Hela and C33A) to verify the bioinformatics analyses results.

View Article and Find Full Text PDF

Objectives: SMAD3 is pivotal in the biology functions of various tumors. This study is aiming to study the relationship among SMAD3, long noncoding RNAs (lncRNAs) OPA-interacting protein 5 antisense transcript 1 (OIP5-AS1), and miR-143-3p, and their effects on cervical cancer.

Methods: In our research, real-time polymerase chain reaction and western blot assay were conducted to detect the expression level of messenger RNA and protein in tumor tissues and cells.

View Article and Find Full Text PDF

[Prognostic Value of Prednisone Response in CCLG-ALL 2008].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

June 2015

Institute of Hematology & Hospital of Blood Disease, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China. E-mail:

Article Synopsis
  • The study aimed to assess how well children with acute lymphoblastic leukemia (ALL) respond to prednisone treatment as a predictor of their prognosis.
  • A total of 598 newly diagnosed ALL patients were treated with prednisone and were divided into two groups based on their lymphoblast counts on day 8: good responders (PGR) and poor responders (PPR).
  • The results showed that PPR patients had poorer outcomes, including lower event-free survival rates and higher relapse rates, suggesting that PPR status indicates a higher risk and worse overall prognosis.*
View Article and Find Full Text PDF

[Research progress in molecular biology of pediatric myelodysplastic syndrome].

Zhongguo Dang Dai Er Ke Za Zhi

September 2014

Department of Pediatric Hematology, Chinese Academy of Medical Science, Peking Union Medical College, Institute of Hematology Hospital of Blood Disease, Tianjin 300020, China.

Marked differences have been found in molecular characteristics between pediatric and adult myelodysplastic syndrome (MDS) patients. The incidence of gene mutations associated with myeloid malignances in pediatric patients is lower than in adults, while the incidence of aberrant methylation is similar between them. It is also worth noting that novel molecular factors such as mitochondrial DNA mutations may play a role in the pathogenesis of childhood MDS.

View Article and Find Full Text PDF

Here we constructed and produced a recombinant human 4-1BB ligand (4-1BBL)/anti-CD20 fusion protein and examined its antitumor activity, alone and in combination with an anti-CD3/anti-CD20 bispecific diabody. The 4-1BBL/anti-CD20 fusion protein retained both the costimulatory activity of 4-1BBL on T cells and the tumor targeting ability of CD20 antibody on B cells. The fusion protein bound as efficiently to 4-1BB- and CD20-positive cells as its respective parental antibodies, and was capable of cross-linking human T lymphocytes and CD20-positive tumor cells.

View Article and Find Full Text PDF

This study was purposed to evaluate the outcome of patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) in complete remission, and to study the prognostic factors. 75 cases of AML in complete remission receiving allo-HSCT from January 2000 to December 2007 were retrospectively analyzed. Major end points of study included overall survival (OS), disease free survival (DFS), relapse rate and transplantation related mortality (TRM).

View Article and Find Full Text PDF
Article Synopsis
  • Multidrug resistance in cancer treatment, caused by the overexpression of P-glycoprotein, severely limits the effectiveness of chemotherapy.
  • The study highlights O-(4-ethoxyl-butyl)-berbamine (EBB) as a promising agent that enhances the effectiveness of doxorubicin against drug-resistant cancer cells by blocking P-glycoprotein's function and reducing its expression.
  • Co-treating cancer cells with EBB and doxorubicin leads to significant cell cycle arrest and increased cell death, indicating a strong potential for improving cancer chemotherapy outcomes.
View Article and Find Full Text PDF

Aim: To construct and express human 4-1BBL/anti-CD20 bispecific fusion protein and identify its biological activity.

Methods: PCR and overlapping PCR were used to construct human 4-1BBL/anti-CD20 bispecific fusion protein. DNA sequencing was performed by the terminus of the fusion protein nucleotide.

View Article and Find Full Text PDF